Category
Pharmaceuticals
-
•
Grassley list keeps track of press coverage
Chuck Grassley is nothing if not media savvy. The senator from Iowa, who is the ranking Republican on the U.S.…
-
•
AHCJ members part of new St. Louis health section
In an encouraging move, the St. Louis Post-Dispatch will be placing greater emphasis on health coverage with the planned launch…
-
•
How marketing turned Zyprexa into blockbuster
Ben Wallace-Wells of Rolling Stone uses the story of the rise of Zyprexa, Eli Lilly’s blockbuster schizophrenia treatment, to look…
-
Stimulus funds study of effectiveness of treatments
Robert Pear reports in The New York Times that $1.1 billion of the $787 billion federal economic stimulus package will…
-
•
Iowa senator calls for FDA transparency
In a Philadelphia Inquirer profile, reporter Miriam Hill says crusading Sen. Charles Grassley (R-Iowa) has turned his sights on the…
-
•
Newer technology not always more effective
Joe Rojas-Burke reported in The Oregonian on what he called “a widespread problem in the health care system: the tendency…
-
•
Smuggled honey may contain dangerous antibiotics
Andrew Schneider of the Seattle Post-Intelligencer spent five months investigating “honey laundering,” the practice of smuggling Chinese honey into the…
-
•
Law may hurt Boston medical convention business
Liz Kowalczyk of The Boston Globe reports that a new Massachusetts law restricting contact between doctors and pharmaceutical companies is…
-
•
Reports shed light on FDA oversight problems
When we talk about FDA oversight, what might we mean? Not too much, according to a pair of new reports…
-
•
Academic docs collect money from manufacturers
In a two-day series, “Side Effects: Are doctor’s loyalties divided?,” John Fauber of the Milwaukee Journal Sentinel reports on university…